Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,969,655
+$17,162,963 QoQ
Shares Held
1,698,341
+134.0% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#67
of 1,016 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
This page
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
866,285 | $4,270,785 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,969,655 | 1,698,341 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,806,692 | 725,884 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,738,971 | 1,424,817 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,969,354 | 1,512,056 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,048,889 | 341,421 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,320,668 | 610,869 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,558,781 | 2,293,878 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,535,248 | 1,338,092 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,024,719 | 378,619 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,238,184 | 522,461 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,689,339 | 155,987 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,135,202 | 216,552 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,342,890 | 334,959 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,292,376 | 446,193 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,334,016 | 569,094 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,180,176 | 490,631 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,236,958 | 691,209 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,570,350 | 420,069 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,420,451 | 252,805 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,345,657 | 246,912 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,240,414 | 296,740 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $577,408 | 41,332 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||